Literature DB >> 31069841

Modulation of cancer cell signaling by long noncoding RNAs.

Seyed Ali Mirhosseini1, Mohammad Sarfi2,3, Sadra Samavarchi Tehrani4, Mohammad Mirazakhani4, Mahmood Maniati5, Jafar Amani1.   

Abstract

Cellular signaling pathways play a very important role in almost all molecular processes in the cell, and are generally composed of a complex set of cascades in which enzymes and proteins play a key role. These signaling pathways include different types of cellular signaling classified based on their receptors and effector proteins such as enzyme-linked receptors, cytokine receptors, and G-protein-coupled receptors each of which is subdivided into different classes. Signaling pathways are tightly controlled by different mechanisms mostly thorough inhibiting/activating their receptors or effector proteins. In the last two decades, our knowledge of molecular biology has changed dramatically and today we know that more than 85% of the human genome expresses noncoding RNAs most of which are crucial in the cellular and molecular mechanisms of cells. One of these noncoding RNAs are long noncoding RNAs (lncRNA) containing more than 200 nucleotides. LncRNAs participate in the progression of cancer growth through several mechanism including signaling pathways. In this review, we summarize some of the most important of lncRNAs and their effect on important signaling pathways.
© 2019 Wiley Periodicals, Inc.

Entities:  

Keywords:  cancer; gene expression; ligand; long noncoding RNAs; signaling pathways

Mesh:

Substances:

Year:  2019        PMID: 31069841     DOI: 10.1002/jcb.28847

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  8 in total

Review 1.  Promising long noncoding RNA DLX6-AS1 in malignant tumors.

Authors:  Chen Xue; Longxian Lv; Jiangwen Jiang; Lanjuan Li
Journal:  Am J Transl Res       Date:  2020-12-15       Impact factor: 4.060

Review 2.  Novel insights into the interaction between long non-coding RNAs and microRNAs in glioma.

Authors:  Anahita Ebrahimpour; Mohammad Sarfi; Setareh Rezatabar; Sadra Samavarchi Tehrani
Journal:  Mol Cell Biochem       Date:  2021-02-13       Impact factor: 3.396

3.  Knockdown of lncRNA MCM3AP-AS1 Attenuates Chemoresistance of Burkitt Lymphoma to Doxorubicin Treatment via Targeting the miR-15a/EIF4E Axis.

Authors:  Chao Guo; Ming Gong; Zhenling Li
Journal:  Cancer Manag Res       Date:  2020-07-16       Impact factor: 3.989

4.  Extracellular Matrix-Related Six-lncRNA Signature as a Novel Prognostic Biomarker for Bladder Cancer.

Authors:  Liangliang Qing; Peng Gu; Mingsheng Liu; Jihong Shen; Xiaodong Liu; Runyun Guang; Kunbin Ke; Zhuo Huang; Wenhui Lee; Hui Zhao
Journal:  Onco Targets Ther       Date:  2020-12-07       Impact factor: 4.147

5.  MicroRNA-26a-5p as a potential predictive factor for determining the effectiveness of trastuzumab therapy in HER-2 positive breast cancer patients.

Authors:  Sadra Samavarchi Tehrani; Ehsan Zaboli; Farzin Sadeghi; Soraya Khafri; Ansar Karimian; Mahnoosh Rafie; Hadi Parsian
Journal:  Biomedicine (Taipei)       Date:  2021-06-01

6.  The tissue expression levels of SUMO1P 3 may be a reliable prognostic biomarker to predict the clinical outcomes in patients with HCC.

Authors:  Henghai Yu; Yitao Bai; Chang Xu; Xin He; Qin Liu; Dou Ma; Yongjun A
Journal:  Medicine (Baltimore)       Date:  2020-11-13       Impact factor: 1.817

7.  A novel antisense lncRNA NT5E promotes progression by modulating the expression of SYNCRIP and predicts a poor prognosis in pancreatic cancer.

Authors:  Pengbo Zhang; Meng Cao; Yi Zhang; Lei Xu; Fanchao Meng; Xinquan Wu; Tianfang Xia; Qun Chen; Guodong Shi; Pengfei Wu; Lei Chen; Zipeng Lu; Jie Yin; Baobao Cai; Shouji Cao; Yi Miao; Kuirong Jiang
Journal:  J Cell Mol Med       Date:  2020-08-08       Impact factor: 5.310

8.  Upregulation of tissue long noncoding RNA X inactive specific transcript predicts poor postoperative survival in patients with non-small cell lung cancer.

Authors:  Hengxiao Fang; Liushan Yang; Yue Fan; Chunrong Mo; Lei Luo; Daying Liang; Yi Jiang
Journal:  Medicine (Baltimore)       Date:  2020-12-11       Impact factor: 1.817

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.